Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia.
We estimated the impact of vancomycin-resistant Enterococcus (VRE) infection on the outcomes of patients with leukemia in a case-control study. Compared with their matched controls (n = 45), cases (n = 23) had 22% greater total charges and shorter survival (P = .04). These findings substantiate the need for aggressive interventions to prevent VRE transmission.
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Peter B
PB
Bach
Sharp F
SF
Malak
Joseph
J
Jurcic
Sarah E
SE
Gelfand
Janet
J
Eagan
Claudia
C
Little
Kent A
KA
Sepkowitz
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D016983:Enterococcus; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000150:complications*; D017048:Health Care Costs; D006801:Humans; D007938:Leukemia / Q000191:economics / Q000382:microbiology* / Q000401:mortality; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009519:New York City / Q000453:epidemiology; D015996:Survival Rate; D020713:Vancomycin Resistance